Medical Updates

Survival Outcomes with Sipuleucel-T Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

Safety and survival outcomes with sipuleucel-T immunotherapy for metastatic castration-resistant prostate cancer (mCRPC) have been analyzed in the...

16 Sep, 2019

Email this page
Visual Prostate Symptom Score Might be a Good Alternative to IPSS in Assessment of Lower Urinary Tract Symptoms

The Visual Prostate Symptom Score (VPSS), which uses pictograms to illustrate some of the questions addressed in International Prostate Symptom...

11 Sep, 2019

Email this page
RLU Better than URL and PCNL In the Treatment of Upper Ureteral Calculi

Retroperitoneal laparoscopic ureterolithotomy (RLU) was associated with higher stone clearance rate and lesser complications especially in ureteral...

27 Aug, 2019

Email this page
Imipenem/Relebactam Effective and Safe in Imipenem Non-Susceptible Gram-Negative Infections

Imipenem/relebactam (IMI/REL) was found to be effective and well-tolerated in the treatment of carbapenem-nonsusceptible infections in high-risk...

23 Aug, 2019

Email this page

Key Trials

Apalutamide Prolongs Survival in Metastatic Castration-Sensitive Prostate Cancer: Findings of TITAN Trial

Addition of enzalutamide to androgen deprivation therapy (ADT) significantly prolonged the overall survival and radiographic progression-free...

Addition of Enzalutamide to Standard First-Line Therapy Prolongs Survival in Metastatic Prostate Cancer

Addition of enzalutamide to standard first line therapy significantly prolonged the overall survival, PSA progression-free survival (PFS) and...

L-Carnitine and L-Acetylcarnitine, Beneficial in Men with Idiopathic Oligoasthenozoospermia

The formulation with L-carnitine (LC) and its active form L-acetylcarnitine exerted beneficial effects on the sperm motility, vitality and DNA...

Vibegron: New Therapeutic Option for Improving Nocturia in Overactive Bladder

Treatment with vibegron was associated with reduction in the frequency of nocturnal voiding, increase in the volume per nocturnal void and volume of...

Slide Library

Tadalafil (Tadaflo)

Erectile dysfunction (ED) and the signs and symptoms of benign prostatic hyperplasia (BPH), are prevalent disorders in middle-aged and older men...

Email this page
Cranberry + D-mannose (Cranfit)

Around 50% of women experience at least one episode of UTI at some point in their lifetime and recurrent UTI occur in about 20-40% of women....

Email this page
Management of Advanced Prostate Cancer: Current Concepts

Prostate cancer has become a major public health burden worldwide and its incidence rates are increasing in India.  Hormonal therapy or androgen...

Email this page
Solifenacin succinate (Soliact)

The overall prevalence of overactive bladder (OAB) in men and women over the age of 40 years is 16.6%. Anticholinergic therapy is currently a...

Email this page

Our Publications

Update on Urolithiasis: Evaluation of Relation between Renal Papillary Abnormalities with Stone Composition and Description into a New Classification by Flexible Ureteroscopy

This update on urolithiasis described the incidence of papillary abnormalities in patients undergoing flexible ureteroscopy and its relation with...

Update on Urolithiasis: Evaluation of the Association of Obesity with Perioperative Outcomes following PCNL in Patients with Kidney Stones

This update on urolithiasis evaluated the association of obesity with adverse outcomes following percutaneous nephrolithotomy.

UTI: Physician Update

Physician update (issue 3) takes you through the recent news & information related to Urinary Tract Infections (UTI) followed by the various...

Role of Pyridoxine in Management of Urolithiasis

This literature provides information on role of pyridoxine in prevention of recurrence of calcium oxalate stones.

Patient Education

All You Wanted to Know about Prostate Cancer

Prostate is one of the most common cancers in men. This material describes risk factors, symptoms, diagnosis and treatment of prostate cancer. Also,...


Explore >>

Currently there is no content under this category.


Which testosterone preparation do you prefer in your patients with late onset hypogonadism?
Testosterone Cypionate/Enanthate
14% (1 vote)
Testosterone undecanoate injection
43% (3 votes)
Testosterone decanoate + testosterone isocaproate + testosterone phenpropionate + testosterone propionate injection
14% (1 vote)
Oral testosterone undecanoate
29% (2 votes)
Testosterone gel
0% (0 votes)
Total votes: 7